Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

References

• LopezADMathersCDEzzatiMJamisonDTMurrayCJGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet200636795241747175716731270
   PubMed Web of Science ®Google Scholar
• PorapakkhamYRaoCPattaraarchachaiJEstimated causes of death in Thailand, 2005: implications for health policyPopul Health Metr201081420482761
   PubMed Web of Science ®Google Scholar
• BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar
• SchwartzGGOlssonAGEzekowitzMDEffects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trialJAMA2001285131711171811277825
   PubMed Web of Science ®Google Scholar
• CannonCPSteinbergBAMurphySAMegaJLBraunwaldEMeta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapyJ Am Coll Cardiol200648343844516875966
   PubMed Web of Science ®Google Scholar
• ReinerZCatapanoALDe BackerGESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J201132141769181821712404
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 Pt B2889293424239923
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceLipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular DiseaseLondon, UKNational Clinical Guideline Centre2014
   Google Scholar
• SilaruksSSriratanasathavornCRawdareePKunjara-Na-AyudhayaRThinkhamropBSritaraPLipid-lowering therapy using statins in patients with cardiovascular risk in clinical practice in ThailandHeart Asia2011399103
   PubMedGoogle Scholar
• SukonthasarnAHomsanitMPrommeteBChotinaiwattarakulCPiamsomboonCLikittanasombatKLipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand surveyJ Med Assoc Thai201194121424143422295727
   PubMedGoogle Scholar
• XanthopoulouIDavlourosPSiahosSPerperisAZaharioglouEAlexopoulosDFirst-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatientsLipids Health Dis20131217024209409
   PubMed Web of Science ®Google Scholar
• AndrikopoulosGTzeisSNikasNShort-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome – results from the countrywide TARGET studyInt J Cardiol2013168292292723186596
   PubMed Web of Science ®Google Scholar
• KimHSWuYLinSJCurrent status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) studyCurr Med Res Opin20082471951196318547466
   PubMed Web of Science ®Google Scholar
• RallidisLSKotakosCSouridesVAttainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dL and impact on prognosis of very high risk stable coronary patients: a 3-year follow-upExpert Opin Pharmacother201112101481148921651448
   PubMed Web of Science ®Google Scholar
• HermansMPCastro CabezasMStrandbergTCentralized Pan-European Survey on the Under-treatment of Hypercholesterolaemia (CEPHEUS): overall findings from eight countriesCurr Med Res Opin201026244545420001658
   PubMed Web of Science ®Google Scholar
• ChinCWGaoFLeTTanRLipid goal attainment and prescription behavior in asian patients with acute coronary syndromes: experience from a tertiary hospitalClin Med Insights Cardiol20137515723533099
   PubMedGoogle Scholar
• KauffmanABOlsonKLYoungbloodMLZadvornyEBDelateTMerenichJAAttainment of low-density lipoprotein cholesterol goals in coronary artery diseaseJ Clin Lipidol20104317318021122649
   PubMed Web of Science ®Google Scholar
• KitkungvanDLynn FilliponNMDaniSSDowneyBCLow-density lipoprotein cholesterol target achievement in patients at high risk for coronary heart diseaseJ Clin Lipidol20104429329721122662
   PubMed Web of Science ®Google Scholar
• KaralisDGVictorBAhedorLLiuLUse of lipid-lowering medications and the likelihood of achieving optimal LDL-cholesterol goals in coronary artery disease patientsCholesterol2012201286192422888414
   PubMedGoogle Scholar
• KaralisDGSubramanyaRDHessenSELiuLVictorMFAchieving optimal lipid goals in patients with coronary artery diseaseAm J Cardiol2011107688689021247526
   PubMed Web of Science ®Google Scholar
• ParkJEChiangCEMunawarMLipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS pan-Asian surveyEur J Prev Cardiol201219478179421450606
   PubMed Web of Science ®Google Scholar
• MelloniCShahBROuFSLipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registryAm Heart J20101606112111291129.e121146667
   PubMed Web of Science ®Google Scholar
• RayKKKasteleinJJBoekholdtSMThe ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011Eur Heart J2014351596096824639424
   PubMed Web of Science ®Google Scholar
• Lopez-JimenezFSimhaVThomasRJA summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gapsMayo Clin Proc20148991257127825131697
   PubMed Web of Science ®Google Scholar
• JacobsonTAItoMKMakiKCNational Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summaryJ Clin Lipidol20148547348825234560
   PubMed Web of Science ®Google Scholar
• CannonCPGiuglianoRPBlazingMARationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromesAm Heart J2008156582683219061694
   PubMed Web of Science ®Google Scholar
• BlazingMAGiuglianoRPCannonCPEvaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study populationAm Heart J20141682205212.e125066560
   PubMed Web of Science ®Google Scholar
• O’RiordanMIMPROVE-IT: ‘Modest’ Benefit When Adding Ezetimibe to Statins in Post-ACS Patients. Medscape Pharmacist Website Available from: http://www.medscape.com/viewarticle/835030Accessed February 23, 2015
   Google Scholar
• LaRosaJCGrundySMKasteleinJJKostisJBGretenHSafety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study)Am J Cardiol2007100574775217719314
   PubMed Web of Science ®Google Scholar
• WiviottSDCannonCPMorrowDARayKKPfefferMABraunwaldECan low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudyJ Am Coll Cardiol20054681411141616226163
   PubMed Web of Science ®Google Scholar
• RayKKBachRGCannonCPBenefits of achieving the NCEP optional LDL-C goal among elderly patients with ACSEur Heart J200627192310231616887854
   PubMed Web of Science ®Google Scholar
• TanNCHoSCTreat-to-target approach in managing modifiable risk factors of patients with coronary heart disease in primary care in Singapore: what are the issues?Asia Pac Fam Med2011101221936960
   PubMedGoogle Scholar
• ParrisESLawrenceDBMohnLALongLBAdherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemiaDiabetes Care200528359559915735194
   PubMed Web of Science ®Google Scholar
• HoPMBrysonCLRumsfeldJSMedication adherence: its importance in cardiovascular outcomesCirculation2009119233028303519528344
   PubMed Web of Science ®Google Scholar
• BerminghamMHaydenJDawkinsIProspective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary careClin Ther20113391180118921840055
   PubMed Web of Science ®Google Scholar
• JackeviciusCAMamdaniMTuJVAdherence with statin therapy in elderly patients with and without acute coronary syndromesJAMA2002288446246712132976
   PubMed Web of Science ®Google Scholar
• ChinwongDPatumanondJChinwongSStatin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potencyTher Clin Risk Manag20151112713625670902
   PubMed Web of Science ®Google Scholar
• GizurarsonSBjornsdottirLREinarsdottirRHalldorssonMAndersenKClinical consequences following regulatory changes in respect to reimbursement of statins cost by the Icelandic Social Insurance AdministrationScand J Public Health201240766366723027893
   PubMed Web of Science ®Google Scholar